Compare LRMR & ELLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LRMR | ELLO |
|---|---|---|
| Founded | N/A | 1987 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 316.6M | 366.5M |
| IPO Year | N/A | 1995 |
| Metric | LRMR | ELLO |
|---|---|---|
| Price | $3.41 | $27.50 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $16.71 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 4.1K |
| Earning Date | 11-05-2025 | 12-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $48,742,227.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 3.31 |
| 52 Week Low | $1.61 | $13.00 |
| 52 Week High | $5.37 | $28.00 |
| Indicator | LRMR | ELLO |
|---|---|---|
| Relative Strength Index (RSI) | 41.31 | 68.18 |
| Support Level | $3.31 | $23.64 |
| Resistance Level | $4.01 | $28.00 |
| Average True Range (ATR) | 0.24 | 1.23 |
| MACD | -0.06 | 0.36 |
| Stochastic Oscillator | 14.34 | 85.47 |
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.
Ellomay Capital Ltd is a renewable energy company. It develops and operates renewable energy projects in Europe, the USA, and Israel, employing diverse technologies such as solar power, natural gas, pumped hydro, and waste-to-energy solutions.